Соматостатин Лиомарк

Соматостатин Лиомарк (Somatostatin Acetate) is a synthetic peptide hormone used in medical treatments requiring somatostatin activity. This sterile intravenous solution is manufactured by Lyomark Pharma GmbH in the EU. It supports conditions where natural somatostatin regulation is beneficial.

Somatostatin Acetate is used in clinical settings to manage conditions involving excessive hormone secretion, such as certain types of tumors or endocrine disorders. It may also be used during specific diagnostic or therapeutic procedures where somatostatin’s effects on hormone release are required. This medication helps regulate processes like growth hormone and insulin release.

As a synthetic analog of somatostatin, this medication works by inhibiting the release of various hormones and peptides in the body. Users may experience effects related to reduced hormone activity, such as changes in blood sugar levels or digestive processes. The effects are typically temporary and depend on the condition being treated.

This medication should only be handled and administered by trained healthcare professionals in a clinical setting. Proper storage and handling are essential to maintain sterility and efficacy. Patients should inform their healthcare provider of any allergies or sensitivities before use.

Somatostatin Acetate may interact with other medications that affect hormone levels or digestive processes, such as insulin or oral hypoglycemics. Caution is advised when used alongside drugs that alter gastrointestinal motility or hormone secretion. Always disclose all medications to your healthcare provider.